Objective. To evaluate the cost-effectiveness of the inclusion of trigger point-dry needling (TrP-DN) into an exercise program for the management of subacromial pain syndrome.
Methods. Fifty patients with unilateral subacromial pain syndrome were randomized with concealed allocation to exercise alone or exercise plus TrP-DN. Both groups were asked to perform an exercise program targeting the rotator cuff musculature twice daily for five weeks. Patients allocated to the exercise plus TrP-DN group also received dry needling during the second and fourth sessions. Societal costs and health-related quality of life (estimated by EuroQol-5D-5L) over a one-year follow-up were used to generate incremental cost per quality-adjusted life-year (QALY) ratios for each intervention.
Results. Intention-to-treat analysis was possible for 48 (96%) of the participants. Those in the exercise group made more visits to medical doctors and received a greater number of other treatments (P < 0.001). The major contributor to societal costs (77%) was the absenteeism paid labor in favor of the exercise plus TrP-DN group (P 5 0.03). The combination of exercise plus TrP-DN was less costly (mean difference cost/patient 5 e517.34, P 5 0.003) than exercise alone. Incremental QALYs showed greater benefit for exercise plus TrP-DN (difference 5 2.87, 95% confidence interval 5 2.85-2.89). Therefore, the inclusion of TrP-DN into an exercise program was more likely to be cost-effective than an exercise program alone, with 99.5% of the iterations falling in the dominant area.
Conclusions. The inclusion of TrP-DN into an exercise program was more cost-effective for individuals

Introduction
Subacromial pain syndrome, as a primary cause of shoulder pain, represents a significant health problem, with a prevalence of 25% in the general population [1] . As shoulder pain has a peak prevalence in middle-aged active workers [2, 3] , subacromial pain syndrome brings high associated health costs and economic burden, including loss of work productivity. The annual costs of shoulder pain have been estimated to be e345 million per year in primary health care in the Netherlands [4] . In Finland, the mean resource-weighted direct cost in primary health care per patient with shoulder pain per year was e543 [5] . In Sweden, the mean annual total cost of a patient with shoulder pain was e4,139 [6] .
Conservative treatment is the first therapeutic option for people with subacromial pain syndrome [7] ; however, the most appropriate treatment strategy is unclear. In fact, several therapeutic interventions, including steroidal injections, oral medications, physical therapy, and exercise, are proposed in current clinical guidelines for subacromial pain syndrome [8] . Among all the interventions, exercise probably exhibits the highest level of evidence for the treatment of subjects with subacromial pain syndrome [9] [10] [11] . As shoulder pain represents a significant health problem, it is the third most common reason for consulting a physical therapist [12] , and physical therapy treatments account for 60% of health costs [6] , an analysis of the economic impact of different physical therapy interventions used for this pain condition is needed.
The cost-effectiveness of physical therapy interventions for shoulder pain has been the subject of a small number of studies. James et al. [13] reported that corticosteroid injections and physical therapy were similarly effective for patients with shoulder pain but corticoid injections were slightly less expensive (mean ¼ £43.32, 95% confidence interval [CI] ¼ £16.21 to £68.03). Kromer et al. [14] observed that individualized exercises showed similar effects on pain and function as manual therapy but resulted in lower costs in the short term (e23.6 6 e10.6). Jowett et al. [15] found that a combination of local steroid injections plus exercises made a marginally more cost-effective use of health care resources than exercise alone (£261 vs £318).
A recent study investigating the effectiveness of the inclusion of trigger point-dry needling (TrP-DN) into an exercise program for subjects with subacromial pain syndrome found that individuals receiving TrP-DN into active TrPs in the shoulder muscles combined with an exercise program exhibited better improvements in shoulder-related disability, and similar changes in pain, than those receiving the exercise program alone at sixand 12-month follow-up [16] . Dry needling is defined as a "skilled intervention using a thin filiform needle to penetrate the skin that stimulates trigger points, muscles, and connective tissue for the management of musculoskeletal disorders" [17] . These results agree with recent meta-analyses suggesting that TrP-DN is an effective intervention for neck and shoulder pain [18, 19] ; however, there is no published trial analyzing health care costs associated with this therapeutic intervention in any pain condition. Therefore, the purpose of the current analysis is to evaluate the cost-effectiveness of the addition of TrP-DN to an exercise program in individuals with subacromial pain syndrome in the aforementioned clinical trial [16] .
Methods
Study Design
An economic evaluation alongside a randomized clinical trial [16] , performed in a general hospital in Madrid, Spain, to evaluate the cost-effectiveness of the inclusion of TrP-DN into an exercise program for people with subacromial pain syndrome was conducted. Full details of the trial, participants, interventions, and results of those clinical outcomes (pain intensity and related disability) have been reported elsewhere [16] . Differences in the analysis and reporting of clinical efficacy and economic evaluation are a reflection of the different research objectives. The study was approved by the Institutional Review Board of Universidad Rey Juan Carlos (URJC 31/2014). The clinical trial was registered at ClinicalTrials.gov (NCT02338908).
Participants
Patients with unilateral nontraumatic shoulder pain of at least three months' duration and pain intensity of at least four points on an 11-point numerical pain rating scale (NPRS) were recruited from an urban hospital in Madrid, Spain. Consistent with the Dutch Orthopedic Association Clinical Practice Guidelines, subacromial pain syndrome was diagnosed using a cluster of tests including a positive painful arc test during shoulder abduction, Hawkins-Kennedy test, Neer's sign, empty can test, drop arm test, and lift-off test [8] . Patients between the ages of 18 and 65 were included if they fulfilled at least three of these tests. They were excluded if they had 1) bilateral shoulder symptoms; 2) a history of shoulder fractures or dislocation; 3) a diagnosis of cervical radiculopathy; 4) previous interventions with steroid injections in the shoulder; 5) fibromyalgia syndrome; 6) a previous history of shoulder or neck surgery; or 7) any type of intervention for the neckshoulder area during the previous year [16] . All participants signed an informed consent prior to their inclusion in the study.
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Interventions
Patients were randomly assigned to receive exercise plus TrP-DN or exercise alone, as described elsewhere [16] . Both groups received the same exercise program based on current clinical guidelines and recommendations [8, 20] . The program included three exercises targeting the supraspinatus, infraspinatus, and scapular stabilizer musculature. Each exercise was performed in three sets of 12 repetitions, and each repetition included first the concentric phase, followed by the eccentric phase of the exercise, which was performed slowly. An experienced therapist monitored the exercise program during all treatment sessions, once a week, during the five-week intervention period. Participants were instructed to perform the exercise program on an individual basis twice daily for the five weeks.
Patients allocated to the TrP-DN group also received TrP-DN during the second and fourth treatment sessions targeting those active TrPs that referred pain reproducing shoulder symptoms using a pragmatic approach [16] . According to previous studies, anterior and middle deltoid, supraspinatus, infraspinatus, teres minor and major, and subscapularis are the muscles most affected in shoulder pain, and these were targeted in the current study [21, 22] . TrP-DN was performed with disposable stainless steel needles of 0.32*40 mm (Novasan, Madrid, Spain) that were inserted into the skin over the TrP. In this study, the fast-in and fast-out technique was applied [23] . Full description of the TrP-DN intervention can be found elsewhere [16] .
Economic Evaluation
A societal perspective including direct health care costs, direct non-health care costs, and indirect costs due to subacromial pain syndrome was used as the basis for economic evaluation [24] . Direct health care costs included the costs of each treatment (i.e., number of sessions, number of visits to medical specialists), additional visits to health care providers (i.e., medical specialist or other health care professional), additional treatments, prescribed medication, and professional home care. Direct non-health care costs included only costs of over-the-counter medication, time spent visiting a health care provider, and travel expenses. Indirect costs of lost productivity due to subacromial pain syndrome-related absence from work were also included in the main analysis. As there is no consensus regarding how economic evaluations should be carried out alongside trials, we used the "within the table" approach, as in most published cost-effectiveness studies.
Data regarding the use of all health care resources during the 12-month follow-up period were assessed. Data were registered by the patients on a health care diary and returned to a research assistant. Direct health and non-health care costs were estimated by averaging the costs of the following five representative regions of Spain (Table 2) .
Outcomes
Health-related quality of life was measured at baseline and at 12 months using the paper-based five-level version of EuroQol-5D (EQ-5D-5L) [31, 32] by an examiner blinded to treatment allocation of the subjects. Responses were converted to an overall utility score by applying crosswalk index values for Spain [33] . In order to mimic the real world and because of the lack of QoL data between baseline and 12 months, we have fitted QoL data to the curve representing the evolution of the Disability of the Arm, Shoulder, and Hand (DASH) questionnaire [34] . We used DASH measures at baseline and one, three, six, and 12 months to create a curve and used baseline and 12-month QoL measures to fit the inbetween time point measures. This process is more realistic than using a linear evolution of the QoL data. DASH was used as there is good evidence supporting its internal consistency, reliability, structural validity, and responsiveness [35] . Quality-adjusted life-years (QALYs) were estimated for each subject using area under the curve analysis, with linear interpolation between observations resulting in the fitting-the-curve exercise [36] . The QALY combines length and quality of life into a single index number between 0 and 1, where 0 corresponds to a health state judged to be equivalent to death and 1 corresponds to optimal health [35] . A graphical analysis of the utility results measured in QALYs was carried out throughout the study follow-up periods. The scatter plot was fitted to a curve for each group to which the individuals were assigned by comparing the trends of both groups (Figure 1 ).
Subsequently, an incremental cost-effectiveness analysis was undertaken using patient responses to the EQ-5D-5L to calculate the cost per additional qualityadjusted life-year gained over the treatment period.
Statistical Analysis
Sample size was based on changes in shoulder relateddisability at one-year follow-up [16] . An incremental cost-effectiveness analysis was performed by intention to treat [24] . To compare costs between groups, we have calculated a deterministic cost-effectiveness value and a probabilistic one using bootstraping techniques and confidence intervals. The 95% confidence intervals were obtained by bias-corrected and accelerated (BCa) bootstrapping, with 1,000 iterations.
The primary outcome was the incremental costeffectiveness ratio, calculated by dividing the incremental cost by the incremental QALY. Uncertainty was explored by graphical display of cost-effectiveness planes and acceptability curves [37] .
One-way sensitivity analysis (OWSA) consisted of calculating the results of the evaluation using a value above that used in the base case and another below, so that we could explore the uncertainty about each parameter by examining the changes in the results in the range of parameter values [38] .
Statistical analysis was performed using STATAV.13.1 for PC (StataCorp, 2014), and cost-effectiveness planes and acceptability curves were generated using Excel 16.0 (Microsoft 2015).
Results
From a total of 50 patients who were initially included in the trial and randomly allocated into the exercise alone group (N ¼ 25) or the exercise plus TrP-DN (N ¼ 25) group; 48 (96%) were included in the final economic analysis (Figure 2 ). Within patients allocated to the exercise group, two subjects were excluded from the original clinical analysis because they received corticosteroid injection in the shoulder area, but they were included in the current economic analysis. The flow of participants leading to the economic analysis is illustrated in Figure 2 . Demographic features did not differ between groups at baseline ( Table 1) . Table 2 summarizes and compares the direct health and non-health care costs of each group. No betweengroup differences were found for per-protocol costs, as both groups received the same number of sessions; however, participants in the exercise group made more visits to their general practitioner and traumatologist (P < 0.001) and received a greater number of other treatments, particularly complementary physiotherapy sessions (P < 0.001), than those in the exercise plus TrP-DN group. Total indirect costs consisted only of lost productivity (work absenteeism) in both groups (Table 2) , which resulted in 77% of societal costs overall. Absenteeism from paid labor was statistically higher in the exercise group than the exercise plus TrP-DN group, both in terms of the number of subjects (17, 68%, vs 2, 8%, P ¼ 0.001) and the mean number of days off from work (805 days vs 56 days, P ¼ 0.014). Similarly, mean cost per subject (including work absence) was statistically higher in the exercise group than the exercise plus TrP-DN group (e733.12 vs e215.78, P ¼ 0.003) ( Table 3) .
Costs
Quality of Life
Utilities estimated over the one-year follow-up were 16.74 QALYs for the exercise group and 19.6 QALYs for the exercise plus TrP-DN group in the deterministic set of results (Table 3) . Incremental QALYs showed significantly greater benefit for exercise plus TrP-DN for the probabilistic set of results (mean difference ¼ 2.87, 95% CI ¼ 2.85 to 2.89). Baseline EQ-5D-5L was a significant independent predictor of 12-month QALYs (mean difference ¼ 0.0015, P ¼ 0.92).
Cost-effectiveness
The deterministic incremental cost-effectiveness ratio was not calculated due to the dominant position of the exercise plus Dominance reflects the direction of the results, always positive (dominant position) in favor of the inclusion of TrP-DN. ICER ¼ incremental cost-effectiveness ratio; QALY ¼ quality-adjusted life-year; TrP-DN ¼ trigger point-dry needling. effectiveness of exercise plus TrP-DN compared with exercise only. Thus, the inclusion of TrP-DN was more likely to be cost-effective than not including it in an exercise program alone, with a99.5% of the iterations falling in the dominant area.
The constructed model was robust for all univariate sensitivity analyzes, where there were no significant changes in the direction of the results of the base case. The results of the univariate sensitivity analyzes are graphically shown within a tornado diagram ( Figure 5 ). Figure 5 shows the five main variables that have been considered that could influence the final results. In the tornado diagram, we observe the vertical line or line of the incremental cost-effectiveness ratio (ICER) for the base case (eÀ4,798.52), and the horizontal bars represent the variables related to greater or lesser variation of the ICER (uncertainty). As shown in Figure 5 , the first (most) uncertainty parameter was "physiotherapy sessions," with an ICER ranging from eÀ5,377.08 to eÀ4,303.03.
Discussion
The purpose of the study was to examine the costeffectiveness of the addition of TrP-DN to an exercise program in individuals with subacromial pain syndrome alongside a randomized clinical trial. Our analysis revealed that the addition of two sessions of TrP-DN to an exercise program resulted in subjects utilizing significantly fewer health care resources than those receiving the exercise program alone. These direct health care costs included visits to additional providers (e.g., primary care physicians and traumatologists) and the use of additional treatments (e.g., cold packs and additional physiotherapy). Moreover, the incorporation of TrP-DN into the exercise program resulted in significantly lower indirect costs, which consisted of lost productivity as a result of work absenteeism (mean difference ¼ eÀ9,954). Individuals who received exercise plus TrP-DN also reported a significantly better quality of life than those receiving exercise alone (difference in QALYs ¼ 2.87). Cost-effectiveness analysis suggested increased effectiveness and cost savings for subjects with subacromial pain syndrome who received two sessions of TrP-DN plus the exercise program as compared with exercise alone.
Few previous published studies have examined the cost-effectiveness of physical therapy interventions for the management of shoulder pain [13] [14] [15] [16] 47, 48] . In a similar study design to the current study, Kromer et al. [14] examined the effectiveness of manual therapy plus exercise to exercise alone in individuals with shoulder impingement. The results demonstrated that the addition of manual therapy did not result in significantly better outcomes or lower costs for both direct and indirect resources. Bergman et al. [48] compared the inclusion Cost-effectiveness of Dry Needling for Shoulder Pain of manual therapy with usual medical care (nonsteroidal anti-inflammatory drugs, corticosteroid injection, or referral to physical therapy) in individuals with shoulder pain complaints. The authors found that although the addition of manual therapy resulted in superior functional outcomes, it did so at greater costs, including higher work absenteeism [48] . It is unclear why individuals in the manual therapy group experienced greater improvements in function yet more time on sick leave. These findings are contrary to our study, as we found significantly better effectiveness for reducing overall costs with the addition of TrP-DN to an exercise program. While this may have occurred for a variety of reasons (e.g., different population, different health care system), it is possible that TrP-DN may result in different therapeutic effects than manual therapy, resulting in an improvement in the individual's ability to perform their job. In fact, this hypothesis would explain the results of the clinical trial, where individuals receiving exercise plus TrP-DN reported larger improvements in pain-related disability and function, but not in the reduction of pain [16] . However, future studies would be required to examine this hypothesis.
In another study to examine work absenteeism, Østerå s et al. [47] assigned 61 individuals with shoulder pain to either a high-dosage exercise therapy group or to a low-dosage exercise group. Both groups received three treatments a week over a three-month time frame. The differences between the groups were number of repetitions, number of sets, and time performing global aerobic exercises. Clinical outcomes and health care costs favored the high-dosage group over the low-dosage group. The reduction in costs for sick leave for the highdosage group was 59.1%, whereas for the low-dosage group, the reduction was 42.3% [47] . It is possible that in individuals with long-standing subacromial pain, higher dosage exercises might be a more efficient treatment approach and would have resulted in overall greater reductions in costs than the exercise approach used in our study [16] . Additionally, Jowett et al. [15] examined the inclusion of exercise to corticosteroid injection for subacromial pain. The results demonstrated that there was a 61% probability that the addition of exercise to corticosteroid injections is cost-effective [15] . The exercise program and dosage differed between the three aforementioned studies, suggesting the need to determine the optimal exercise approach in terms of function and cost-effectiveness for this chronic pain population.
James et al. [13] found that individuals with shoulder pain who were randomized to receive corticosteroid injections experienced similar outcomes yet reduced direct costs in comparison with a group that received physical therapy. However, indirect costs including lost work time were not reported in this study, and the physical therapy treatment was not clearly defined [13] . In the current study, the greatest cost savings by the inclusion of TrP-DN were associated with lost productivity associated with work absenteeism. These are of utmost importance as Virta et al. [6] reported that the total costs associated with sick leave for individuals with shoulder pain represented 84% of all costs. This is similar to Kuijpers et al. [4] , who found that nearly 50% of all indirect costs for individuals with shoulder pain were a direct result of sick leave from the place of employment. These findings mandate the need to identify optimal treatment methods to improve function, specifically the ability to perform work duties in subjects with subacromial pan syndrome. Our findings suggest that the incorporation of Figure 5 Tornado diagram of one-way sensitivity analysis. ICER ¼ incremental cost-effectiveness ratio; PT ¼ physical therapy.
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two sessions of TrP-DN reduced work absenteeism in patients with subacromial pain syndrome, which may have significant socioeconomic consequences.
Although this is the first cost-effectiveness analysis investigating TrP-DN for any musculoskeletal pain condition, we recognize some limitations that should be considered when generalizing the results of the current study. First, we did not have a control group, so we cannot be certain that TrP-DN and exercise would be superior in terms of QALYs and cost-effectiveness than no treatment. Future research should consider whether allocation to a wait-and-see policy may allow for more or less cost-effective resource use. Second, data were collected in a Spanish health care system in a specific geographical location in Spain, and we cannot be certain that the findings would be similar if carried out in other countries. We tried to broaden this generalizability by including cost calculations across five different regions, which likely represents the national costs of this pain condition. Further, differences in health care systems across countries-for example, different costs of a treatment session according to the intervention applied (TrP-DN or not), application of TrP-DN in the same or a different treatment session, or other particular professional issues-should be considered with caution at this stage. Nevertheless, these differences would not alter the direction of current results. Lastly, this economic evaluation was based on the clinical outcome at 12 months after therapy and therefore did not investigate short-or mid-term costs.
Conclusions
The present study is the first to investigate the costeffectiveness of the addition of TrP-DN to an exercise program for patients with subacromial pain syndrome. The results suggest that the addition of TrP-DN to an exercise program may result in improved quality of life and lower direct and indirect costs than exercise alone. The largest cost savings came from less work absenteeism in participants who received the addition of TrP-DN into their exercise program. Future studies should examine the cost-effectiveness of commonly used interventions for the management of shoulder pain, including TrP-DN combined with other interventions.
